It has become apparent that Acadia Pharmaceuticals Inc (NASDAQ:ACAD) needs a commercial partner for Nuplazid to maintain ACAD stock value long-term.
Important stories and news related to XPO Logistics (XPO stock), Under Armour, Fannie Mae (FNMA stock), ACAD stock, and CLF stock.
A bidding war for Acadia Pharmaceuticals and Nuplazid is likely to ensue after buyout rumors last Friday. Great news for ACAD stock owners.
Alkermes stock, VRX stock, Acadia Pharmaceuticals, and Vertex Pharmaceuticals were all discussed in our first Biotech Hunter.
Why ACAD stock will be the next Medivation. Pfizer, Gilead, Teva, Bristol-Myers, Otsuka & AbbVie are all companies that would want Nuplazid & Acadia Pharma
Acadia Pharmaceuticals’ Nuplazid is reportedly seeing a rise in off label use, specifically With Lewy Body Dementia. That’s great news for ACAD stock.